首页> 外文期刊>Genetic Testing >Facioscapulohumeral Muscular Dystrophy Type 1A in Northwestern Tuscany: A Molecular Genetics-based Epidemiological and Genotype-Phenotype Study
【24h】

Facioscapulohumeral Muscular Dystrophy Type 1A in Northwestern Tuscany: A Molecular Genetics-based Epidemiological and Genotype-Phenotype Study

机译:西北托斯卡纳的面肩肱型肌营养不良症1A型:基于分子遗传学的流行病学和基因型-表型研究

获取原文
获取原文并翻译 | 示例
           

摘要

Facioscapulohumeral muscular dystrophy type 1A (FSHD1A) is an autosomal dominant inherited disorder characterized by early involvement of facial and scapular muscles with eventual spreading to pelvic and lower limb muscles. A high degree of clinical variability with respect to age at onset, severity, and pattern of muscle involvement, both between and within families, is present. For this reason, diagnosis of FSHD1A can be sometimes difficult and molecular diagnosis is then necessary. A clinical and molecular genetic-based epi-demiological investigation has been carried out in the territory of northwestern Tuscany in central Italy to calculate the prevalence rate of FSHD1A as of March, 2004. The molecular diagnosis has been based on the detection of large deletions of variable size of kpnl repeat units on chromosome 4q35. Results have been compared to those of a previous study conducted in the same area in 1981 (in the premolecular diagnosis era). The minimum prevalence rate was 4.60 X 10~(-5) inhabitants, a value four times higher compared to our previous study. No significant correlation between fragment size and clinical severity has been observed. This study confirms in an Italian population a prevalence rate of FSHD1A similar to that observed in other populations. Furthermore, it underlines the usefulness of routine adoption of the genetic testing in confirming clinical suspicion of FSHD1A as well as in correctly diagnosing atypical and otherwise misclassified cases.
机译:1A型肩肱肱型肌营养不良症(FSHD1A)是常染色体显性遗传遗传疾病,其特征是面部和肩cap骨肌早期受累,最终扩散到骨盆和下肢肌肉。在家庭之间和家庭内部,存在关于发病年龄,严重性和肌肉受累方式的高度临床变异性。因此,有时可能难以诊断FSHD1A,因此必须进行分子诊断。在意大利中部托斯卡纳西北部地区,进行了基于临床和分子遗传学的流行病学调查,以计算FSHD1A的患病率(截至2004年3月)。分子诊断是基于对大分子缺失的检测。染色体4q35上kpnl重复单元大小可变。将结果与1981年在同一地区(分子前诊断时代)进行的先前研究的结果进行了比较。最低患病率为4.60 X 10〜(-5)居民,比我们以前的研究高四倍。片段大小与临床严重性之间未发现显着相关性。这项研究证实了意大利人群中FSHD1A的患病率与其他人群中观察到的相似。此外,它强调了常规进行基因检测在确认FSHD1A的临床怀疑以及正确诊断非典型和其他分类错误的病例中的有用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号